Speakers: Rif S. El-Mallakh (University of Louisville School of Medicine), Alexander Niculescu III ( Indiana University School of Medicine), Todd D. Gould (University of Maryland), Haim Einat (University of Minnesota and Tel-Hai College, Israel)Sponsored by the Biochemical Pharmacology Discussion Group and Brain Dysfunction Discussion Group
Reported by Kathleen McGowan | Posted March 16, 2010
Bipolar disorder is a severe mood disorder with physiological consequences that include brain shrinkage, functional changes in brain activity, and cellular ionic imbalances. The biology and cause of the illness remain unknown, as are the therapeutic mechanisms of action of lithium, a major treatment for the illness.
Researchers convened at the Academy on December 15, 2009, to discuss new approaches toward understanding bipolar disorder and the development of more effective treatment for the illness. Topics discussed included new animal models for bipolar, genetic and genomic analyses, and possible biomarkers for the illness.
Use the tabs above to find a meeting report and multimedia from this event.Log in or Join Now to continue